Skip to main content
. Author manuscript; available in PMC: 2019 Jan 16.
Published in final edited form as: Acta Trop. 2015 Oct 28;165:155–160. doi: 10.1016/j.actatropica.2015.10.018

Table 1.

Number and percentage (%) of study subjects Ag-ELISA seropositive and seronegative with a confirmed history of epilepsy and respective brain CT-scan findings.*

Brain CT-scan findings Ag-ELISA positive + epilepsy Ag-ELISA negative + epilepsy
No. of study subjects % No. of study subjects %
Vesicular 19 18.8 1 2.3
Colloidal 8 7.5 1 2.3
Nodular-granular 4 3.7 4 9.1
Calcified 35 32.7 2 4.5
Fibrous arachnoiditis 1 0.9 0 0.0
Cysticercotic encephalitis 3 2.8 0 0.0
Vesicular + calcified 7 6.5 0 0.0
Normal CT-scan 30 28.0 36 81.8
Total 107 100 44 100
*

CT: computed tomography scan; Ag-ELISA: antigen-Enzyme-Linked Immunosorbent Assay.